Related Experiment Video

Updated: Apr 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Cancer Genetics and Implications for Clinical Management

Nigel B Jamieson1, David K Chang2, Andrew V Biankin2

  • 1Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK; Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, Glasgow Royal Infirmary, University of Glasgow, Alexandra Parade, Glasgow G31 2ER, UK; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Alexandra Parade, Glasgow G31 2ER, UK.

The Surgical Clinics of North America
|August 29, 2015
PubMed

Insights

Cancer molecular heterogeneity drives diverse patient outcomes and treatment responses. Understanding these molecular differences enables personalized medicine, improving therapeutic selection and patient results.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Cancer exhibits significant molecular heterogeneity, leading to varied clinical phenotypes and treatment responses even in histologically similar tumors.
  • Conventional clinical trials often fail due to patient unselection, masking potential treatment efficacy in specific molecular subtypes.
  • Molecular profiling is crucial for understanding tumor diversity and its impact on patient prognosis.

Purpose of the Study:

  • To highlight the importance of molecular heterogeneity in cancer.
  • To underscore the limitations of unselected patient enrollment in clinical trials.
  • To advocate for a stratified healthcare approach based on molecular phenotypes for improved therapeutic selection and patient outcomes.

Main Methods:

  • Review of existing evidence on cancer molecular heterogeneity.
  • Analysis of the impact of molecular diversity on therapeutic responsiveness.
  • Discussion of challenges and potential solutions for stratified healthcare.

Main Results:

  • Molecular heterogeneity is a key determinant of cancer phenotypes, outcomes, and treatment response.
  • Unselected patient enrollment in trials limits the demonstration of treatment efficacy.
  • Stratified approaches promise more precise diagnostics and tailored therapies.

Conclusions:

  • Addressing molecular heterogeneity is essential for advancing cancer treatment.
  • Personalized diagnostics and therapeutics based on molecular phenotypes can significantly improve patient outcomes.
  • A shift towards precision medicine is necessary to overcome current therapeutic challenges.
Keywords:
GenomicsNext-generation sequencingPancreatic cancerStratified medicineTranslational medicine

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

10.1K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.3K